Management of chronic recurrent multifocal osteomyelitis: review and update on the treatment protocol

References

• Taddio A, Zennaro F, Pastore S, et al. An update on the Pathogenesis and treatment of Chronic Recurrent Multifocal Osteomyelitis in Children. Paediatr Drugs. 2017;19(3):165–172.
   PubMed Web of Science ®Google Scholar
• Schnabel A, Range U, Hahn G, et al. Unexpectedly high incidences of chronic non-bacterial as compared to bacterial osteomyelitis in children. Rheumatol Int. 2016;36(12):1737–1745.
   PubMed Web of Science ®Google Scholar
• Oliver M, Lee TC, Halpern-Felsher B, et al. Disease burden and social impact of pediatric chronic nonbacterial osteomyelitis from the patient and family perspective. Pediatr Rheumatol Online J. 2018;16(1):78.
   PubMedGoogle Scholar
• Wipff J, Adamsbaum C, Kahan A, et al. Chronic recurrent multifocal osteomyelitis. Joint Bone Spine. 2011;78(6):555–560.
   PubMed Web of Science ®Google Scholar
• Huaux JP, Esselinckx W, Rombouts JJ, et al. Pustulotic arthroosteitis and chronic recurrent multifocal osteomyelitis in children. Report of three cases. J Rheumatol. 1988;15(1):95–100.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wu EY, Oliver MS, et al., Consensus treatment plans for Chronic Nonbacterial Osteomyelitis Refractory to Nonsteroidal antiinflammatory drugs and/or with active spinal lesions. Arthritis Care Res (Hoboken). 70(8): 1228–1237. 2018.
   PubMed Web of Science ®Google Scholar
• Schnabel A, Range U, Hahn G, et al. Treatment response and longterm outcomes in children with Chronic Nonbacterial Osteomyelitis. J Rheumatol. 2017;44(7):1058–1065.
   PubMed Web of Science ®Google Scholar
• Gamalero L, Belot A, Zajc Avramovic M, et al. Chronic non-bacterial osteomyelitis: a retrospective international study on clinical manifestations and response to treatment. Clin Exp Rheumatol. 2020;38(6):1255–1262.
   PubMed Web of Science ®Google Scholar
• Roderick MR, Sen ES, Ramanan AV. Chronic recurrent multifocal osteomyelitis in children and adults: current understanding and areas for development. Rheumatology (Oxford). 2018;57(1):41–48.
   PubMed Web of Science ®Google Scholar
• Beck C, Morbach H, Beer M, et al. Chronic nonbacterial osteomyelitis in childhood: prospective follow-up during the first year of anti-inflammatory treatment. Arthritis Res Ther. 2010;12(2):R74.
   PubMed Web of Science ®Google Scholar
• Hofmann SR, Schnabel A, Rosen-Wolff A, et al. Chronic nonbacterial osteomyelitis: pathophysiological concepts and current treatment strategies. J Rheumatol. 2016;43(11):1956–1964.
   PubMed Web of Science ®Google Scholar
• Hedrich CM, Hofmann SR, Pablik J, et al. Autoinflammatory bone disorders with special focus on chronic recurrent multifocal osteomyelitis (CRMO). Pediatr Rheumatol Online J. 2013;11(1):47.
   PubMedGoogle Scholar
• Job-Deslandre C, Krebs S, Kahan A. Chronic recurrent multifocal osteomyelitis: five-year outcomes in 14 pediatric cases.J Bone Spine.2001;68:245–251. 3
   PubMed Web of Science ®Google Scholar
• Abril JC, Ramirez A. Successful treatment of Chronic Recurrent Multifocal Osteomyelitis with indomethacin. J Ped Orthop. 2007;27(5):587–591.
   PubMed Web of Science ®Google Scholar
• Pastore S, Ferrara G, Monasta L, et al. Chronic nonbacterial osteomyelitis may be associated with renal disease, and bisphosphonates are a good option for the majority of patients. Acta Paediatr. 2016;105(7):e328–33.
   PubMed Web of Science ®Google Scholar
• Kostik MM, Kopchak OL, Maletin AS, et al. The peculiarities and treatment outcomes of the spinal form of chronic non-bacterial osteomyelitis in children: a retrospective cohort study. Rheumatol Int. 2020;40(1):97–105.
   PubMed Web of Science ®Google Scholar
• Ishikawa-Nakayama K, Sugiyama E, Sawazaki S, et al. Chronic recurrent multifocal osteomyelitis showing marked improvement with corticosteroid treatment. J Rheumatol. 2000;27(5):1318–1319.
   PubMed Web of Science ®Google Scholar
• Walsh P, Manners PJ, Vercoe J, et al., Chronic recurrent multifocal osteomyelitis in children: nine years’ experience at a statewide tertiary paediatric rheumatology referral center. Rheumatology (Oxford). 54(9): 1688–1691. 2015.
   PubMed Web of Science ®Google Scholar
• Sözeri B, Ayaz NA, Atıkan BY, et al. Clinical experiences in Turkish paediatric patients with chronic recurrent multifocal osteomyelitis. Turk J Pediatr. 2019;61(6):879–884.
   PubMed Web of Science ®Google Scholar
• Açoğlu EA, Akçaboy M, Yıldız YT, et al. Chronic recurrent multifocal osteomyelitis: a case report. Turk Pediatri Ars. 2019;54(4):272–276.
   PubMedGoogle Scholar
• Borzutzky A, Stern S, Reiff A, et al. Pediatric Chronic Nonbacterial Osteomyelitis. Pediatrics. 2012;130(5):e1190–7.
   PubMed Web of Science ®Google Scholar
• Wipff J, Costantino F, Lemelle I, et al. A large national cohort of French patients with chronic recurrent multifocal osteitis. Arthritis Rheumatol. 2015;67(4):1128–1137.
   PubMed Web of Science ®Google Scholar
• Jansson A, Renner ED, Ramser J, et al. Classification of non-bacterial osteitis: a retrospective study of clinical, immunological and genetic aspects in 89 patients. Rheumatology (Oxford). 2007;46(1):154–160.
   PubMedGoogle Scholar
• Kaiser D, Bolt I, Hofer M, et al. Chronic nonbacterial osteomyelitis in children: a retrospective multicenter study. Pediatr Rheumatol Online J. 2015;13(1):25.
   PubMedGoogle Scholar
• Catalano-Pons C, Comte A, Wipff J, et al. The outcome in children with chronic recurrent multifocal osteomyelitis. Rheumatology (Oxford). 2008;47(9):1397–1399.
   PubMed Web of Science ®Google Scholar
• Girschick H, Finetti M, Orlando F, et al., The multifaceted presentation of chronic recurrent multifocal osteomyelitis: a series of 486 cases from the Euro fever international registry. Rheumatology (Oxford). 57(7): 1203–1211. 2018.
   PubMed Web of Science ®Google Scholar
• Bhat CS, Anderson C, Harbinson A, et al. Chronic nonbacterial osteitis- a multicentre study. Pediatr Rheumatol Online J. 2018;16(1):74.
   PubMedGoogle Scholar
• Concha S, Hernández-Ojeda A, Contreras O, et al. Chronic nonbacterial osteomyelitis in children: a multicenter case series. Rheumatol Int. 2020;40(1):115–120.
   PubMed Web of Science ®Google Scholar
• Marangoni RG, Halpern AS. Chronic recurrent multifocal osteomyelitis primarily affecting the spine treated with anti-TNF therapy. Spine (Phila Pa 1976). 2010;35(7):E253–6.
   PubMed Web of Science ®Google Scholar
• Carpenter E, Jackson MA, Friesen CA, et al. Crohn’s-associated chronic recurrent multifocal osteomyelitis responsive to infliximab. J Pediatr. 2004;144(4):541–544.
   PubMed Web of Science ®Google Scholar
• Coinde E, David L, Cottalorda J, et al. Chronic recurrent multifocal osteomyelitis in children: report of 17 cases. Arch Pediatr. 2001;8(6):577–583.
   PubMed Web of Science ®Google Scholar
• Vries E, van der Weij JP, van der Veen CJ, et al. In vitro effect of (3-amino-1-hydroxypropylidene)-1,1-bisphosphonic acid (APD) on the function of mononuclear phagocytes in lymphocyte proliferation. Immunology. 1982;47(1):157–163.
   PubMed Web of Science ®Google Scholar
• Pennanen N, Lapinjoki S, Urtti A, et al. Effect of liposomal and free bisphosphonates on the IL-1 beta, IL-6 and TNF alpha secretion from RAW 264 cells in vitro. Pharm Res. 1995;12(6):916–922.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Chauvin NA, Jaramillo D, et al. Aggressive Therapy Reduces Disease Activity without Skeletal Damage Progression in Chronic Nonbacterial Osteomyelitis. J Rheumatol. 2015;42(7):1245–1251.
   PubMed Web of Science ®Google Scholar
• Sułko J, Ebisz M, Bień S, et al. Treatment of chronic recurrent multifocal osteomyelitis with bisphosphonates in children. Joint Bone Spine. 2019;86(6):783–788.
   PubMed Web of Science ®Google Scholar
• Miettunen PM, Wei X, Kaura D, et al. Dramatic pain relief and resolution of bone inflammation following pamidronate in 9 pediatric patients with persistent chronic recurrent multifocal osteomyelitis (CRMO). Pediatr Rheumatol Online J. 2009;7(1):2.
   PubMedGoogle Scholar
• Hirano D, Chiba K, Yamada S, et al. Oral alendronate in pediatric chronic recurrent multifocal osteomyelitis. Pediatr Int. 2017;59(4):506–508.
   PubMed Web of Science ®Google Scholar
• Hospach T, Langendoerfer M, von Kalle T, et al. Spinal involvement in chronic recurrent multifocal osteomyelitis (CRMO) in childhood and effect of pamidronate. Eur J Pediatr. 2010;169(9):1105–1111.
   PubMed Web of Science ®Google Scholar
• Ramanan AV, Hampson LV, Lythgoe H, et al. Defining consensus opinion to develop randomized controlled trials in rare diseases using Bayesian design: an example of a proposed trial of Adalimumab versus pamidronate for children with CRMO/CRMO. PLoS One. 2019;14(6):e0215739.
   Google Scholar
• Green SB, Pappas AL. Effects of maternal bisphosphonate use on fetal and neonatal outcomes. Am J Health Syst Pharm. 2014;71(23):2029–2036.
   PubMed Web of Science ®Google Scholar
• Cavalli G, Dinarello CA. Corrigendum: anakinra Therapy for non-cancer Inflammatory Diseases. Front Pharmacol. 2019;10:148.
   PubMed Web of Science ®Google Scholar
• Eleftheriou D, Gerschman T, Sebire N, et al. Biologic therapy in refractory chronic non-bacterial osteomyelitis of childhood. Rheumatology. 2010;49(8):1505–1512.
   PubMed Web of Science ®Google Scholar
• Wendling D, Prati C, Aubin F. Anakinra treatment of SAPHO syndrome: short-term results of an open study. Ann Rheum Dis. 2012;71(6):1098–1100.
   PubMed Web of Science ®Google Scholar